LIFEMD, INC. (LFMD)

3.14 -3.68% (-0.12)

Over 5Y: -60.8%

2026-08-28
5 10 15
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 60.2M Q3 '25 — Operating Cash Flow: -147.1K Q3 '25 — Free Cash Flow: -968.1K Q3 '25 — Net Income: -3.8M Q4 '25 — Revenue: 7.1M Q4 '25 — Operating Cash Flow: -3.3M Q4 '25 — Free Cash Flow: -3.4M Q4 '25 — Net Income: 20M Q1 '26 — Revenue: 50.2M Q1 '26 — Operating Cash Flow: 444.6K Q1 '26 — Free Cash Flow: 339.4K Q1 '26 — Net Income: -8.9M Q2 '26 — Revenue: 47.3M Q2 '26 — Operating Cash Flow: -6.9M Q2 '26 — Free Cash Flow: -7M Q2 '26 — Net Income: -7.1M 0 15M 30M 45M 60M 75M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.6
OE margin -11.6%
Oper. margin -14.7%
Gross margin 86.1%
ROE 2.5%
Accruals 16.9%
EBITDA margin -14.0%
FCF margin -6.7%
OCF margin -6.0%
ROA 0.34%
ROCE -182.6%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.5
RPO / sales 0.066×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.8
ND/EBITDA —
Interest cover -16.6×
Debt / Eq 0.0×
Debt payback 0.0 yr
Cash runway 2.3 yr
F-score 5.6 pts
Quick ratio 0.84×
Payout 1545.3%
Cash / Debt —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales CAGR 4Y +20.2%
Sales/sh Y/Y -5.3%
Div. growth +0.0%
Sales Q/Q -3.5%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.